Johannes Leierer

Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease

Hiddo J.L. Heerspink, Paul Perco, Skander Mulder et al. · Diabetologia · 2019 · 441 citations · Full text

Renal micro<scp>RNA</scp>‐ and <scp>RNA</scp>‐profiles in progressive chronic kidney disease

Michael A. Rudnicki, Paul Perco, Barbara D′haene et al. · European Journal of Clinical Investigation · 2015 · 109 citations

Urine proteomics for prediction of disease progression in patients with IgA nephropathy

Michael Rudnicki, Justyna Siwy, Ralph Wendt et al. · Nephrology Dialysis Transplantation · 2020 · 77 citations · Full text

Hypoxia up‐regulates the angiogenic cytokine secretoneurin <i>via</i> an HIF‐1α‐ and basic FGF‐dependent pathway in muscle cells

Margot Egger, Wilfried Schgoer, Arno Beer et al. · The FASEB Journal · 2007 · 66 citations

Considerable international variation exists in blood pressure control and antihypertensive prescription patterns in chronic kidney disease

Natália Alencar de Pinho, Adeera Levin, Masafumi Fukagawa et al. · Kidney International · 2019 · 66 citations · Full text

Hypertension, Urology, Renal Disease +13